Zobrazeno 1 - 10
of 29
pro vyhledávání: '"B A Nanaeva"'
Publikováno v:
Терапевтический архив, Vol 90, Iss 4, Pp 50-54 (2018)
Aim. To assess the effectiveness of conservative treatment of Crohn's disease (CD) with perianal lesions. Materials and methods. The study included 20 patients with CD with perianal fistulae. Prior to the start of conservative therapy, 7 patients und
Externí odkaz:
https://doaj.org/article/f6394a0246714cd0800e155fa427cc22
Publikováno v:
Терапевтический архив, Vol 87, Iss 6, Pp 83-87 (2015)
Aim. To determine the efficacy of 0.1% tacrolimus ointment in patients with perianal Crohn’s disease (CD). Subjects and methods. This prospective randomized trial enrolled 20 patients with perianal CD as anal fissures and rectal fistulas. The inclu
Externí odkaz:
https://doaj.org/article/42b5482d65af4d238f7a531e38d409a8
Publikováno v:
Терапевтический архив, Vol 87, Iss 2, Pp 34-38 (2015)
Aim. To assess the long-term result of medical treatment in patients with a severe attack (SA) of ulcerative colitis (UC). Subjects and methods. The course of UC was analyzed in 56 patients who were accessible by telephone contact and consecutively r
Externí odkaz:
https://doaj.org/article/3448e30e9b4f47a693ef79acd0915ca8
Autor:
M. V. Shapina, B. A. Nanaeva
Publikováno v:
Терапевтический архив, Vol 92, Iss 2, Pp 67-73 (2020)
Vedolizumab is currently the only selective biological drug for the treatment of inflammatory bowel diseases (IBD). Its effectiveness and safety has been shown in clinical trials. This article presents the experience of using vedolizumab in real clin
Externí odkaz:
https://doaj.org/article/bda8c5011b7e4f6fbc2096f56751b4f8
Publikováno v:
Koloproktologia. 22:128-137
Treatment of аnal fistulas as perianal manifestations of Crohn’s disease is an important task, the solution of which has not yet been found. First of all, this is due to debilitating symptoms that reduce the quality of life. Incorrect tactics in t
Autor:
E. A. Belousova, Yu. A. Shelygin, S. I. Achkasov, I. E. Khatkov, I. G. Bakulin, M. I. Skalinskaya, O. V. Knyazev, A. V. Kagramanova, T. V. Shkurko, B. A. Nanaeva, N. V. Nikitina, M. N. Zakharova, L. V. Tarasova, O. P. Alekseeva, M. V. Zlobin, V. V. Pavlenko, E. V. Mishchenko, A. I. Dolgushina, A. V. Lakhin, A. V. Tkachev, D. I. Abdulganieva, O. V. Vasilyeva, I. V. Gubonina
Publikováno v:
Koloproktologia. 22:65-82
The National Registry of Patients with Inflammatory Bowel Disease (IBD) in the Russian Federation was established to study the epidemiological and clinical characteristics of patients and evaluate the actual clinical practice of medical and surgical
Publikováno v:
Koloproktologia. 22:83-90
AIM: to evaluate the effect of intestinal anastomosis type on risk of Crohn’s disease (CD) recurrence.PATIENTS AND METHODS: the retrospective cohort study included 130 patients with CD who underwent surgery for a complicated CD in 2012–2017. Ileo
Autor:
A. F. Mingazov, A. V. Vardanyan, O. I. Sushkov, D. G. Shahmatov, B. A. Nanaeva, T. A. Baranova, S. E. Katorkin, N. V. Kostenko, S. I. Achkasov
Publikováno v:
Koloproktologia. 22:45-53
AIM: to improve the results of treatment of patients with «extremely severe» ulcerative colitis (UC).PATIENTS AND METHODS: A multicenter observational prospective «case-control» study was conducted. The study included 71 patients with «extremely
Autor:
I. A. Tishaeva, O. V. Knyazev, T. A. Baranova, D. V. Podolskaya, T. L. Alexandrov, B. A. Nanaeva
Publikováno v:
Koloproktologia. 22:99-107
AIM: detection of steroid dependence and steroid resistance predictors in patients with ulcerative colitis (UC).PATIENTS AND METHODS: a retrospective study was conducted. The medical documentation of 1105 patients, who underwent inpatient treatment i
Publikováno v:
Koloproktologia. 22:147-159
The incidence of ulcerative colitis (UC) and Crohn’s disease (CD) worldwide falls on the childbearing age. High activity of inflammatory bowel diseases (IBD) during pregnancy is a risk factor for the development of obstetric complications, and ther